Chemistry:Tazomeline
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C14H23N3S2 |
Molar mass | 297.48 g·mol−1 |
3D model (JSmol) | |
|
Tazomeline (LY-287,041) is a drug which acts as a non-selective muscarinic acetylcholine receptor agonist.[1][2] It was in clinical trials for the treatment of cognitive dysfunction such as that seen in Alzheimer's disease and schizophrenia, but development was apparently scrapped for unknown reasons.[1][2][3] Another of the patented uses is for the treatment of "severe painful conditions".
See also
References
- ↑ 1.0 1.1 "Muscarinic acetylcholine receptors as CNS drug targets". Pharmacology & Therapeutics 117 (2): 232–43. February 2008. doi:10.1016/j.pharmthera.2007.09.009. PMID 18082893.
- ↑ 2.0 2.1 Amos D Korczyn (October 2000). "Muscarinic M1 Agonists in the Treatment of Alzheimer's Disease". Expert Opinion on Investigational Drugs 9 (10): 2259–2267(9). doi:10.1517/13543784.9.10.2259. PMID 11060805.
- ↑ "Drugs for the Treatment of Alzheimer's Disease". Pharmaceutical Chemistry Journal 35 (4): 179–182. April 2001. doi:10.1023/A:1010474325601.
Original source: https://en.wikipedia.org/wiki/Tazomeline.
Read more |